Search company, investor...
Search
Trutino Biosciences company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

trutinobio.com

Founded Year

2018

Stage

Acquired | Acquired

Total Raised

$1.5M

About Trutino Biosciences

On June 14th, 2022, Trutino Biosciences was acquired by Boehringer Ingelheim. Terms of the transaction were not disclosed. Trutino Biosciences is a pre-clinical stage biotech company dedicated to the discovery and development of safe and effective next-generation cytokine therapies. Its goal is to enable the full therapeutic power of cytokines in Immuno-Oncology and Autoimmune Diseases (AD) by developing ZytokinesTM, pro-cytokines engineered to be activated and retained at the disease sites. The company was founded in 2018 and is based in San Diego, California.

Trutino Biosciences Headquarters Location

San Diego, California,

United States

858-880-5501

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Trutino Biosciences Patents

Trutino Biosciences has filed 2 patents.

The 3 most popular patent topics include:

  • Immunology
  • Abandoned drugs
  • Cancer treatments
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/31/2020

Immune system, Immunology, Clusters of differentiation, Cancer treatments, Oncology

Application

Application Date

1/31/2020

Grant Date

Title

Related Topics

Immune system, Immunology, Clusters of differentiation, Cancer treatments, Oncology

Status

Application

Latest Trutino Biosciences News

Germany: Boehringer Ingelheim signs option to acquire Trutino Biosciences

Jun 16, 2022

Germany-based Boehringer Ingelheim, a leading biopharmaceutical company, has signed an option to acquire Trutino Biosciences (Trutino), a San Diego-based pre-clinical stage biotech company dedicated to the discovery and development of next-generation cytokine therapies to treat immuno-oncology and autoimmune diseases. Under the agreement, Boehringer Ingelheim reserves the right to purchase all shares of Trutino once specified […]

  • When was Trutino Biosciences founded?

    Trutino Biosciences was founded in 2018.

  • Where is Trutino Biosciences's headquarters?

    Trutino Biosciences's headquarters is located at San Diego.

  • What is Trutino Biosciences's latest funding round?

    Trutino Biosciences's latest funding round is Acquired.

  • How much did Trutino Biosciences raise?

    Trutino Biosciences raised a total of $1.5M.

  • Who are the investors of Trutino Biosciences?

    Investors of Trutino Biosciences include Boehringer Ingelheim and Partners Investment.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.